Kesler Norman & Wride LLC Acquires New Holdings in iShares Biotechnology ETF $IBB

Posted by on Jun 4th, 2026

Kesler Norman & Wride LLC bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,335 shares of the financial services provider’s stock, valued at approximately $563,000.

Several other hedge funds and other institutional investors have also bought and sold shares of the stock. Brighton Jones LLC purchased a new position in iShares Biotechnology ETF in the fourth quarter valued at about $201,000. AQR Capital Management LLC purchased a new position in shares of iShares Biotechnology ETF in the 1st quarter worth approximately $455,000. Millennium Management LLC grew its position in shares of iShares Biotechnology ETF by 140.8% in the 1st quarter. Millennium Management LLC now owns 41,676 shares of the financial services provider’s stock worth $5,330,000 after buying an additional 143,893 shares during the last quarter. M&T Bank Corp raised its stake in shares of iShares Biotechnology ETF by 39.3% during the 2nd quarter. M&T Bank Corp now owns 2,660 shares of the financial services provider’s stock worth $337,000 after acquiring an additional 750 shares in the last quarter. Finally, Walleye Capital LLC lifted its position in iShares Biotechnology ETF by 26.8% during the second quarter. Walleye Capital LLC now owns 4,655 shares of the financial services provider’s stock valued at $589,000 after acquiring an additional 985 shares during the last quarter. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 2.0%

NASDAQ IBB opened at $167.50 on Thursday. iShares Biotechnology ETF has a 12-month low of $123.61 and a 12-month high of $179.64. The firm’s fifty day simple moving average is $169.70 and its two-hundred day simple moving average is $170.51.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, March 20th. Stockholders of record on Tuesday, March 17th were paid a dividend of $0.1218 per share. The ex-dividend date was Tuesday, March 17th. This represents a $0.49 dividend on an annualized basis and a dividend yield of 0.3%.

About iShares Biotechnology ETF

(Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Stories

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Biotechnology ETF (NASDAQ:IBB – Free Report).

Institutional Ownership by Quarter for iShares Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.